Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada

Emerging Infectious Diseases

Volumn 8, Issue 2, 2002, Pages 181-187

  Speert, David P ^a,d   Henry, Deborah ^a   Vandamme, Peter ^b   Corey, Mary ^c   Mahenthiralingam, Eshwar ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b GHENT UNIVERSITY   (Belgium)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d Research Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM IDENTIFICATION; BURKHOLDERIA CEPACIA; CANADA; CYSTIC FIBROSIS; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; STRAIN DIFFERENCE;

EID: 0036193728     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0802.010163     Document Type: Article

References (37)

1. Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia
2. Infection with Pseudomonas cepacia in chronic granulomatous disease: Role of nonoxidative killing by neutrophils in host defense
3. Pseudomonas cepacia infection in cystic fibrosis: An emerging problem
4. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis
5. Intercontinental spread of a highly transmissible clone of Pseudomonas cepacia proved by multilocus enzyme electrophoresis and ribotyping
6. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis
7. Epidemiology of Pseudomonas cepacia in cystic fibrosis
8. Burkholderia cepacia respiratory tract acquisition: Epidemiology and molecular characterization of a large nosocomial outbreak
9. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis
10. Determinants of mortality from cystic fibrosis in Canada, 1970-1989
11. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.
12. Burkholderia cepacia: Management issues and new insights
13. + Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain
14. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis
15. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex
16. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium
17. DNA-based diagnostic approaches for the identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, Burkholderia cepacia genomovars I and III
18. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosisrelated isolates
19. Species-specific PCR as a tool for the identification of Burkholderia gladioli
20. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: Analysis by random amplified polymorphic DNA (RAPD) fingerprinting
21. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis
22. Description of Pandoraea gen. nov. with Pandoraea pulmonicola sp. nov., Pandoraea apista sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov, and Pandoraea norimbergensis comb. nov.
23. Burkholderia fungorum sp. nov. and Burkholderia caledonica sp. nov., two new species isolated from the environment, animals and human clinical samples
24. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: Virulent transmissible strains of genomovar III can replace B. multivorans
25. Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: A diagnostic pitfall with major clinical implications
26. Misidentification of Burkholderia cepacia in U.S. cystic fibrosis treatment centers: An analysis of 1051 recent sputum isolates
27. Burkholderia cepacia genomovar III is a common plant-associated bacterium
28. Burkholderia cepacia complex: Distribution of genomovars among isolates from the maize rhizosphere in Italy
29. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak
30. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates
31. Spread of B-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic
32. Spread of multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic
33. Long-term outbreak of a transmissible virulent strain of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic
34. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis
35. Burkholderia cepacia and cystic fibrosis: Do natural environments present a potential hazard?
36. Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment
37. Burkholderia cepacia: Medical, taxonomic and ecological issues